Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2020 Q2- Text added to 2020 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
New words:
begun, Biopharma, bore, cast, comprised, depressing, divested, entry, indirect, interaction, Legault, LIBOR, London, lone, outlined, Overnight, PDUFA, pharmacovigilance, Pierre, pro, pushdown, rata, repaid, revolving, SOFR, stability, Sumitovant, turn, undergo, unsecured, waiver
Removed:
arrange, authorizing, blinded, commissioned, diagnosed, episode, ER, fourth, screening
Valuein 2020 Q2 filing- Value in 2020 Q3 filing
Original filings
Filing view